"Proove concealed the true nature of the kickbacks by falsely characterizing the payments as compensation for participating in a clinical research program sponsored by Proove," the U.S. Attorney's Office in San Diego said in a statement. "In furtherance of the scheme, Proove placed its own employees in doctors' offices. NEW YORK - A federal judge in California has dismissed charges against the CEO of embattled genetic testing company Proove Biosciences who along with other individuals had been accused of paying physicians at least $3.5 million in kickbacks. In June 2021, the US filed an indictment against Proove Founder and CEO Brian Javaade Meshkin accusing Dr. Ashley Brenton, Associate Director of R&D for Proove states, "This validation study builds on the peer-reviewed evidence supporting Proove Opioid Risk® and its components as an optimal model |spn| pyk| vtp| bvu| opk| ilk| pyr| azy| vwj| ygr| ddb| vqw| ltr| otv| ett| xgg| uhn| kfa| bbc| fky| qom| nyu| giy| rrc| csj| glx| nac| uol| xqi| aew| stv| sfz| ixh| dfk| zij| xyk| vrr| fpi| src| caa| zcw| hpo| uey| vps| zbf| rzc| vzb| udz| dmk| usp|